Israel Englander Dare Bioscience, Inc. Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.82 - $1.03 $42,458 - $53,332	-51,779 Reduced 29.88%	121,523 $101,000
Q3 2022 Nov 14, 2022	SELL	$1.04 - $1.27 $282,655 - $345,165	-271,784 Reduced 61.06%	173,302 $173,000
Q2 2022 Aug 15, 2022	BUY	$0.94 - $1.76 $177,745 - $332,800	189,091 Added 73.87%	445,086 $547,000
Q1 2022 May 16, 2022	BUY	$1.42 - $2.09 $363,512 - $535,029	255,995 New	255,995 $381,000
Q4 2021 Feb 14, 2022	SELL	$1.42 - $2.13 $38,486 - $57,729	-27,103 Closed	0 $0

Q3 2021 Nov 15, 2021	BUY	$1.42 - $2.0 $38,486 - $54,206	27,103 New	27,103 $45,000
Q4 2017 Feb 14, 2018	SELL	$2.16 - $3.35 $39,776 - $61,690	-18,415 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.63 - $3.52 $48,431 - $64,820	18,415	18,415 $57,000

6.86M

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $28.8M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.